GlassScriptPhysician profile
Lisa Bryce Lopez
NPI 1821109323
$1,906.32
in general payments reported to CMS, 2019-2025
16 companies · $381 in 2025
The $381 reported for 2025 was more than what 90% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.59 · 2020: $160 · 2021: $24.71 · 2022: $80.00 · 2023: $463 · 2024: $752 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,595.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $1,098.55 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $282.87 | 2022-2025 | Azstarys |
| Tris Pharma INC | $107.16 | 2020 | |
| Ironshore Pharmaceuticals INC. | $102.28 | 2020-2024 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $56.76 | 2025 | |
| Pfizer INC. | $37.98 | 2023 | |
| Collegium Pharmaceutical, INC. | $34.08 | 2025 | Jornay Pm |
| Shire North American Group INC | $29.68 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.08 | 2022 | |
| Glaxosmithkline, LLC. | $25.95 | 2020-2022 | |
| Verrica Pharmaceuticals INC. | $24.79 | 2025 | Ycanth |
| Sanofi Pasteur INC. | $17.78 | 2025 | |
| Philips North America LLC | $15.91 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.80 | 2020 | |
| Sobi, INC | $14.67 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $13.98 | 2023 | Flucelvax Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.